✦ LIBER ✦

Growth inhibition of breast cancer cells by Grb2 downregulation is correlated with inactivation of mitogen-activated protein kinase in EGFR, but not in ErbB2, cells

✍ Scribed by Tari, Ana Maria; Hung, Mien-Chie; Li, Kaiyi; Lopez-Berestein, Gabriel

Book ID: 110061874
Publisher: Nature Publishing Group
Year: 1999
Tongue: English
Weight: 301 KB
Volume: 18
Category: Article
ISSN: 0950-9232
DOI: 10.1038/sj.onc.1202422

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inhibition of serum-stimulated mitogen a

Inhibition of serum-stimulated mitogen activated protein kinase by 1α,25(OH)2-vitamin D3 in MCF-7 breast cancer cells

✍ Daniela A. Capiati; Ana M. Rossi; Gabriela Picotto; Silvia Benassati; Ricardo L. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 378 KB 👁 1 views

## Abstract 1α,25‐Dihydroxyvitamin D~3~ [1α,25(OH)~2~D~3~], the hormonally active form of vitamin D~3~, has been shown to be a potent negative growth regulator of breast cancer cells both in vitro and in vivo. 1α,25(OH)~2~D~3~ acts through two different mechanisms. In addition to regulating gene tr

Cell growth inhibition by all-trans reti

Cell growth inhibition by all-trans retinoic acid in SKBR-3 breast cancer cells: Involvement of protein kinase Cα and extracellular signal-regulated kinase mitogen-activated protein kinase

✍ Shino Nakagawa; Teruhiko Fujii; Goro Yokoyama; Marcelo G. Kazanietz; Hideaki Yam 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 359 KB

## Abstract All‐trans retinoic acid (ATRA), a synthetic derivative of vitamin A, inhibits the growth of breast cancer cells. To elucidate the mechanism by which ATRA causes cell growth inhibition, we examined changes in cell cycle and intracellular signaling pathways, focusing on protein kinase C (

Expression of epidermal growth factor re

Expression of epidermal growth factor receptor 1 (EGFR1) is correlated with over-expression of c-erbB-2, and higher expression of the angiogenic factors basic fibroblast growth factor (BFGF) and vascular endothelial growth factor (VEGF), but do not add prognostic information in primary breast cancer

✍ B.K. Linderholm; B. Lindh; B. Tavelin; M. Erlanson; L. Beckman; K. Grankvist; R. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 196 KB